Transglutaminase 2 at the crossroads between cell death and survival

Advances in Enzymology and Related Areas of Molecular Biology

Volumn 78 1, Issue , 2011, Pages 197-246

  Piacentini, Mauro ^a   D'eletto, Manuela ^a   Falasca, Laura ^a   Farrace, Maria Grazia ^a   Rodolfo, Carlo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

ANIMAL; AUTOPHAGY; BIOLOGICAL MODEL; CELL DEATH; CELL SURVIVAL; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CHEMICAL STRUCTURE; DISEASES; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; AUTOPHAGY; CELL DEATH; CELL PHYSIOLOGICAL PROCESSES; CELL SURVIVAL; DISEASE; GTP-BINDING PROTEINS; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; SIGNAL TRANSDUCTION; TRANSGLUTAMINASES;

EID: 84856623167     PISSN: 0065258X     EISSN: None     Source Type: Book Series    
DOI: 10.1002/9781118105771.ch5     Document Type: Article

References (274)

1. Folk, J. E. and Finlayson, J. S. (1977) The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases, Adv. Protein Chem. 31, 1.
2. Lorand, L. and Conrad, S. M. (1984) Transglutaminases, Mol. Cell. Biochem. 58, 9.
3. Grenard, P., Bates, M. K., and Aeschlimann, D. (2001) Evolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. Structure of the gene encoding transglutaminase X and a novel gene family member, transglutaminase Z, J. Biol. Chem. 276, 33066.
4. Makarova, K. S., Aravind, L., and Koonin, E. V. (1999) A superfamily of archaeal, bacterial, and eukaryotic proteins homologous to animal transglutaminases, Protein Sci. 8, 1714.
5. Mosher, D. F., Schad, P. E., and Kleinman, H. K. (1979) Inhibition of blood coagulation factor XIIIa-mediated cross-linking between fibronectin and collagen by polyamines, J. Supramol. Struct. 11, 227.
6. Kim, S. Y., Kim, I. G., Chung, S. I., and Steinert, P. M. (1994) The structure of the transglutaminase 1 enzyme. Deletion cloning reveals domains that regulate its specific activity and substrate specificity, J. Biol. Chem. 269, 27979.
7. Rice, R. H. and Green, H. (1978) Relation of protein synthesis and transglutaminase activity to formation of the cross-linked envelope during terminal differentiation of the cultured human epidermal keratinocyte, J. Cell Biol. 76, 705.
8. Fesus, L. and Piacentini, M. (2002) Transglutaminase 2: an enigmatic enzyme with diverse functions, Trends Biochem. Sci. 27, 534.
9. Lorand, L. and Graham, R. M. (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions, Nat. Rev. Mol. Cell Biol. 4, 140.
10. Lee, J. H., Jang, S. I., Yang, J. M., Markova, N. G., and Steinert, P. M. (1996) The proximal promoter of the human transglutaminase 3 gene. Stratified squamous epithelialspecific expression in cultured cells is mediated by binding of Sp1 and ets transcription factors to a proximal promoter element, J. Biol. Chem. 271, 4561.
11. Dubbink, H. J., De Waal, L., Van Haperen, R., Verkaik, N. S., Trapman, J., and Romijn, J. C. (1998) The human prostate-specific transglutaminase gene (TGM4): genomic organization, tissue-specific expression, and promoter characterization, Genomics 51, 434.
12. Candi, E., Oddi, S.,Terrinoni, A., Paradisi, A., Ranalli, M., Finazzi-Agro, A., andMelino, G. (2001) Transglutaminase 5 cross-links loricrin, involucrin, and small proline-rich proteins in vitro, J. Biol. Chem. 276, 35014.
13. Lee, C. J., Do, B. R., Lee, J. M., Song, K. W., Kang, J. S., and Park, M. H. (2003) Differential expression of tissue transglutaminase protein in mouse ovarian follicle, In Vivo 17, 235.
14. Polakowska, R. R., Graf, B. A., Falciano, V., and LaCelle, P. (1999) Transcription regulatory elements of the first intron control human transglutaminase type I gene expression in epidermal keratinocytes, J. Cell Biochem. 73, 355.
15. Im,M. J. and Graham, R.M. (1990) A novel guanine nucleotide-binding protein coupled to the alpha 1-adrenergic receptor. I. Identification by photolabeling or membrane and ternary complex preparation, J. Biol. Chem. 265, 18944.
16. Im, M. J., Riek, R. P., and Graham, R. M. (1990) A novel guanine nucleotide-binding protein coupled to the alpha 1-adrenergic receptor. II. Purification, characterization, and reconstitution, J. Biol. Chem. 265, 18952.
17. Spina, A. M., Esposito, C., Pagano, M., Chiosi, E., Mariniello, L., Cozzolino, A., Porta, R., and Illiano, G. (1999) GTPase and transglutaminase are associated in the secretion of the rat anterior prostate, Biochem. Biophys. Res. Commun. 260, 351.
18. Candi, E., Paradisi, A., Terrinoni, A., Pietroni, V., Oddi, S., Cadot, B., Jogini, V., Meiyappan, M., Clardy, J., Finazzi-Agro, A., and Melino, G. (2004) Transglutaminase 5 is regulated by guanine-adenine nucleotides, Biochem. J. 381, 313.
19. Liu, S., Cerione, R. A., and Clardy, J. (2002) Structural basis for the guanine nucleotidebinding activity of tissue transglutaminase and its regulation of transamidation activity, Proc. Natl. Acad. Sci. U.S.A. 99, 2743.
20. Nakaoka, H., Perez, D. M., Baek, K. J., Das, T., Husain, A., Misono, K., Im, M. J., and Graham, R. M. (1994) Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function, Science 264, 1593.
21. Mishra, S. and Murphy, L. J. (2004) Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase, J. Biol. Chem. 279, 23863.
22. Mishra, S. and Murphy, L. J. (2006) The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity, Biochem. Biophys. Res. Commun. 339, 726.
23. Mishra, S., Saleh, A., Espino, P. S., Davie, J. R., and Murphy, L. J. (2006) Phosphorylation of histones by tissue transglutaminase, J. Biol. Chem. 281, 5532.
24. Hasegawa, G., Suwa, M., Ichikawa, Y., Ohtsuka, T., Kumagai, S., Kikuchi,M., Sato, Y., and Saito, Y. (2003) A novel function of tissue-type transglutaminase: protein disulphide isomerase, Biochem. J. 373, 793.
25. Mastroberardino, P. G., Farrace, M. G., Viti, I., Pavone, F., Fimia, G. M., Melino, G., Rodolfo, C., and Piacentini, M. (2006) " Tissue" transglutaminase contributes to the formation of disulphide bridges in proteins of mitochondrial respiratory complexes, Biochim. Biophys. Acta 1757, 1357.
26. Ueki, S., Takagi, J., and Saito, Y. (1996) Dual functions of transglutaminase in novel cell adhesion, J. Cell Sci. 109(Pt 11), 2727.
27. Lorand, L. (1988) Transglutaminase-mediated cross-linking of proteins and cell ageing: the erythrocyte and lens models, Adv. Exp. Med. Biol. 231, 79.
28. Kim, S. Y., Jeitner, T. M., and Steinert, P. M. (2002) Transglutaminases in disease, Neurochem. Int. 40, 85.
29. D'Amato, M., Iannicola, C., Monteriu, G., and Piacentini, M. (1999), Mapping and sequencing of the murine 'tissue' transglutaminase (Tgm2) gene: absence of mutations in MRLlpr/lpr mice, Cell Death Differ. 6, 216.
30. Gentile, V., Davies, P. J., and Baldini, A. (1994), The human tissue transglutaminase gene maps on chromosome 20q12 by in situ fluorescence hybridization, Genomics 20, 295.
31. Fraij, B. M. and Gonzales, R. A. (1997), Organization and structure of the human tissue transglutaminase gene, Biochim. Biophys. Acta 1354, 65.
32. Gentile, V., Saydak, M., Chiocca, E. A., Akande, O., Birckbichler, P. J., Lee, K. N., Stein, J. P., and Davies, P. J. (1991) Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases, J. Biol. Chem. 266, 478.
33. Fesus, L. and Arato, G. (1986), Quantitation of tissue transglutaminase by a sandwich ELISA system, J. Immunol. Methods 94, 131.
34. Thomazy, V. and Fesus, L. (1989) Differential expression of tissue transglutaminase in human cells. An immunohistochemical study, Cell Tissue Res. 255, 215.
35. Di Venere, A., Rossi, A., De Matteis, F., Rosato, N., Agro, A. F., andMei, G. (2000) Opposite effects of Ca(2+) and GTP binding on tissue transglutaminase tertiary structure, J. Biol. Chem. 275, 3915.
36. Pedersen, L. C., Yee, V. C., Bishop, P. D., Le Trong, I., Teller, D. C., and Stenkamp, R. E. (1994) Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules, Protein Sci. 3, 1131.
37. Yee, V. C., Pedersen, L. C., Le Trong, I., Bishop, P. D., Stenkamp, R. E., and Teller, D. C. (1994) Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII, Proc. Natl. Acad. Sci. U.S.A. 91, 7296.
38. Noguchi, K., Ishikawa, K., Yokoyama, K., Ohtsuka, T., Nio, N., and Suzuki, E. (2001) Crystal structure of red sea bream transglutaminase, J. Biol. Chem. 276, 12055.
39. Singh, U. S., Erickson, J. W., and Cerione, R. A. (1995) Identification and biochemical characterization of an 80 kilodalton GTP-binding/transglutaminase from rabbit liver nuclei, Biochemistry 34, 15863.
40. Malorni, W., Farrace, M. G., Matarrese, P., Tinari, A., Ciarlo, L., Mousavi-Shafaei, P., D'Eletto, M., Di Giacomo, G., Melino, G., Palmieri, L., Rodolfo, C., and Piacentini, M. (2009) The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis, Cell Death Differ. 16, 1480.
41. Piacentini, M., Farrace, M. G., Piredda, L., Matarrese, P., Ciccosanti, F., Falasca, L., Rodolfo, C., Giammarioli, A. M., Verderio, E., Griffin, M., and Malorni, W. (2002), Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress, J. Neurochem. 81, 1061.
42. Gaudry, C. A., Verderio, E., Aeschlimann, D., Cox, A., Smith, C., and Griffin, M. (1999) Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal beta-sandwich domain, J. Biol. Chem. 274, 30707.
43. Gaudry, C. A., Verderio, E., Jones, R. A., Smith, C., and Griffin, M. (1999) Tissue transglutaminase is an important player at the surface of human endothelial cells: evidence for its externalization and its colocalization with the beta(1) integrin, Exp. Cell Res. 252, 104.
44. Stevens, H. Y., Reeve, J., and Noble, B. S. (2000) Bcl-2, tissue transglutaminase and p53 protein expression in the apoptotic cascade in ribs of premature infants, J. Anat. 196(Pt 2), 181.
45. Radek, J. T., Jeong, J. M., Murthy, S. N., Ingham, K. C., and Lorand, L. (1993) Affinity of human erythrocyte transglutaminase for a 42-kDa gelatin-binding fragment of human plasma fibronectin, Proc. Natl. Acad. Sci. U.S.A. 90, 3152.
46. Akimov, S. S., Krylov, D., Fleischman, L. F., and Belkin, A. M. (2000) Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin, J. Cell Biol. 148, 825.
47. Telci, D., Wang, Z., Li, X., Verderio, E. A., Humphries, M. J., Baccarini, M., Basaga, H., and Griffin, M. (2008) Fibronectin-tissue transglutaminase matrix rescues RGDimpaired cell adhesion through syndecan-4 and beta1 integrin co-signaling, J. Biol. Chem. 283, 20937.
48. Xu, L., Begum, S., Hearn, J. D., and Hynes, R. O. (2006) GPR56, an atypical G proteincoupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis, Proc. Natl. Acad. Sci. U.S.A. 103, 9023.
49. Vezza, R., Habib, A., and FitzGerald, G. A. (1999) Differential signaling by the thromboxane receptor isoforms via the novel GTP-binding protein, Gh, J. Biol. Chem. 274, 12774.
50. Park, E. S., Won, J. H., Han, K. J., Suh, P. G., Ryu, S. H., Lee, H. S., Yun, H. Y., Kwon, N. S., and Baek, K. J. (1998) Phospholipase C-delta1 and oxytocin receptor signalling: evidence of its role as an effector, Biochem. J. 331(Pt 1), 283.
51. Rodolfo, C., Mormone, E., Matarrese, P., Ciccosanti, F., Farrace, M. G., Garofano, E., Piredda, L., Fimia, G. M., Malorni, W., and Piacentini, M. (2004) Tissue transglutaminase is a multifunctional BH3-only protein, J. Biol. Chem. 279, 54783.
52. Piacentini, M., Rodolfo, C., Farrace, M. G., and Autuori, F. (2000) " Tissue" transglutaminase in animal development, Int. J. Dev. Biol. 44, 655.
53. Szegezdi, E., Szondy, Z., Nagy, L., Nemes, Z., Friis, R. R., Davies, P. J., and Fesus, L. (2000) Apoptosis-linked in vivo regulation of the tissue transglutaminase gene promoter, Cell Death Differ. 7, 1225.
54. Iismaa, S. E., Chung, L., Wu, M. J., Teller, D. C., Yee, V. C., and Graham, R. M. (1997) The core domain of the tissue transglutaminase Gh hydrolyzes GTP and ATP, Biochemistry 36, 11655.
55. Iismaa, S. E., Wu, M. J., Nanda, N., Church, W. B., and Graham, R. M. (2000) GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket, J. Biol. Chem. 275, 18259.
56. Murthy, S. N., Lomasney, J. W., Mak, E. C., and Lorand, L. (1999) Interactions of G(h)/transglutaminase with phospholipase Cdelta1 and with GTP, Proc. Natl. Acad. Sci. U.S.A. 96, 11815.
57. Lai, T. S., Bielawska, A., Peoples, K. A., Hannun, Y. A., and Greenberg, C. S. (1997) Sphingosylphosphocholine reduces the calcium ion requirement for activating tissue transglutaminase, J. Biol. Chem. 272, 16295.
58. Lai, T. S., Hausladen, A., Slaughter, T. F., Eu, J. P., Stamler, J. S., and Greenberg, C. S. (2001) Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase, Biochemistry 40, 4904.
59. Singh, U. S.,Kunar, M. T.,Kao,Y. L., and Baker,K.M. (2001), Role of transglutaminase II in retinoic acid-induced activation of RhoA-associated kinase-2, Embo. J. 20, 2413.
60. Singh, U. S., Pan, J., Kao, Y. L., Joshi, S., Young, K. L., and Baker, K. M. (2003), Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic acid-induced neuronal differentiation of SH-SY5Y cells, J. Biol. Chem. 278, 391.
61. Murthy, S. N., Wilson, J. H., Lukas, T. J., Kuret, J., and Lorand, L. (1998) Crosslinking sites of the human tau protein, probed by reactions with human transglutaminase, J. Neurochem. 71, 2607.
62. Piredda, L., Farrace, M. G., Lo Bello, M., Malorni, W., Melino, G., Petruzzelli, R., and Piacentini, M. (1999) Identification of 'tissue' transglutaminase binding proteins in neural cells committed to apoptosis, Faseb. J. 13, 355.
63. Peng, X., Zhang, Y., Zhang, H., Graner, S., Williams, J. F., Levitt, M. L., and Lokshin, A. (1999) Interaction of tissue transglutaminase with nuclear transport protein importinalpha3, FEBS Lett. 446, 35.
64. Ballestar, E., Abad, C., and Franco, L. (1996) Core histones are glutaminyl substrates for tissue transglutaminase, J. Biol. Chem. 271, 18817.
65. Ballestar, E., Boix-Chornet, M., and Franco, L. (2001) Conformational changes in the nucleosome followed by the selective accessibility of histone glutamines in the transglutaminase reaction: effects of ionic strength, Biochemistry 40, 1922.
66. Oliverio, S., Amendola, A., Di Sano, F., Farrace, M. G., Fesus, L., Nemes, Z., Piredda, L., Spinedi, A., and Piacentini, M. (1997) Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis, Mol. Cell Biol. 17, 6040.
67. Fesus, L., Thomazy, V., Autuori, F., Ceru, M. P., Tarcsa, E., and Piacentini, M. (1989) Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action, FEBS Lett. 245, 150.
68. Fesus, L., Thomazy, V., and Falus, A. (1987) Induction and activation of tissue transglutaminase during programmed cell death, FEBS Lett. 224, 104.
69. Oliverio, S., Amendola, A., Rodolfo,C., Spinedi, A., and Piacentini, M. (1999) Inhibition of " tissue" transglutaminase increases cell survival by preventing apoptosis, J. Biol. Chem. 274, 34123.
70. Tatsukawa, H., Fukaya, Y., Frampton, G., Martinez-Fuentes, A., Suzuki, K., Kuo, T. F., Nagatsuma, K., Shimokado, K., Okuno, M.,Wu, J., Iismaa, S., Matsuura, T., Tsukamoto, H., Zern, M. A., Graham, R. M., and Kojima, S. (2009) Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1, Gastroenterology 136, 1783.
71. Polakowska, R. R., Piacentini, M.,Bartlett, R.,Goldsmith, L. A., andHaake, A. R. (1994) Apoptosis in human skin development: morphogenesis, periderm, and stem cells, Dev. Dyn. 199, 176.
72. Szondy, Z., Molnar, P., Nemes, Z., Boyiadzis, M., Kedei, N., Toth, R., and Fesus, L. (1997) Differential expression of tissue transglutaminase during in vivo apoptosis of thymocytes induced via distinct signalling pathways, FEBS Lett. 404, 307.
73. Szondy, Z., Reichert, U., Bernardon, J. M., Michel, S., Toth, R., Ancian, P., Ajzner, E., and Fesus, L. (1997) Induction of apoptosis by retinoids and retinoic acid receptor gamma-selective compounds in mouse thymocytes through a novel apoptosis pathway, Mol. Pharmacol. 51, 972.
74. Nagy, L., Thomazy, V. A., and Davies, P. J. (1998) A transgenic mouse model for the study of apoptosis during limb development, Cell Death Differ. 5, 126.
75. Thomazy, V. A. and Davies, P. J. (1999) Expression of tissue transglutaminase in the developing chicken limb is associated bothwith apoptosis and endochondral ossification, Cell Death Differ. 6, 146.
76. Sarang, Z., Madi, A., Koy, C., Varga, S., Glocker, M. O., Ucker, D. S., Kuchay, S., Chishti, A. H., Melino, G., Fesus, L., and Szondy, Z. (2007) Tissue transglutaminase (TG2) facilitates phosphatidylserine exposure and calpain activity in calcium-induced death of erythrocytes, Cell Death Differ. 14, 1842.
77. Nemes, Z., Jr., Friis, R. R., Aeschlimann, D., Saurer, S., Paulsson, M., and Fesus, L. (1996) Expression and activation of tissue transglutaminase in apoptotic cells of involuting rodent mammary tissue, Eur. J. Cell Biol. 70, 125.
78. Ruan, Q., Quintanilla, R. A., and Johnson, G. V. (2007) Type 2 transglutaminase differentially modulates striatal cell death in the presence of wild type or mutant huntingtin, J. Neurochem. 102, 25.
79. Rebe, C., Raveneau, M., Chevriaux, A., Lakomy, D., Sberna, A. L., Costa, A., Bessede, G., Athias, A., Steinmetz, E., Lobaccaro, J. M., Alves, G., Menicacci, A., Vachenc, S., Solary, E., Gambert, P., and Masson, D. (2009) Induction of transglutaminase 2 by a liverXreceptor/retinoic acid receptor alpha pathway increases the clearance of apoptotic cells by human macrophages, Circ. Res. 105, 393.
80. Ou, H., Haendeler, J., Aebly, M. R., Kelly, L. A., Cholewa, B. C., Koike, G., Kwitek-Black, A., Jacob, H. J., Berk, B. C., and Miano, J. M. (2000) Retinoic acid-induced tissue transglutaminase and apoptosis in vascular smooth muscle cells, Circ. Res. 87, 881.
81. Gorza, L., Menabo, R., Di Lisa, F., and Vitadello, M. (1997) Troponin T cross-linking in human apoptotic cardiomyocytes, Am. J. Pathol. 150, 2087.
82. Gorza, L., Menabo, R., Vitadello, M., Bergamini, C. M., and Di Lisa, F. (1996) Cardiomyocyte troponin T immunoreactivity is modified by cross-linking resulting from intracellular calcium overload, Circulation 93, 1896.
83. Assisi, L., Autuori, F., Botte, V., Farrace, M. G., and Piacentini, M. (1999) Hormonal control of " tissue" transglutaminase induction during programmed cell death in frog liver, Exp. Cell Res. 247, 339.
84. Lin, X. R., Wilkinson, D. I., and Farber, E. M. (1998) Camptothecin induces differentiation, tissue transglutaminase and apoptosis in cultured keratinocytes, Exp. Dermatol. 7, 179.
85. Zhang, S. R., Li, S. H., Abler, A., Fu, J., Tso, M. O., and Lam, T. T. (1996) Tissue transglutaminase in apoptosis of photoreceptor cells in rat retina, Invest. Ophthalmol. Vis. Sci. 37, 1793.
86. Dini, L., Falasca, L., Lentini, A., Mattioli, P., Piacentini, M., Piredda, L., and Autuori, F. (1993) Galactose-specific receptor modulation related to the onset of apoptosis in rat liver, Eur. J. Cell Biol. 61, 329.
87. Fesus, L., Tarcsa, E., Kedei, N., Autuori, F., and Piacentini, M. (1991) Degradation of cells dying by apoptosis leads to accumulation of epsilon(gamma-glutamyl)lysine isodipeptide in culture fluid and blood, FEBS Lett. 284, 109.
88. Amendola, A., Gougeon, M. L., Poccia, F., Bondurand, A., Fesus, L., and Piacentini, M. (1996) Induction of " tissue" transglutaminase in HIV pathogenesis: evidence for high rate of apoptosis of CD4+ T lymphocytes and accessory cells in lymphoid tissues, Proc. Natl. Acad. Sci. U.S.A. 93, 11057.
89. Nardacci, R., Antinori, A., Larocca, L. M., Arena, V., Amendola, A., Perfettini, J. L., Kroemer, G., and Piacentini, M. (2005) Characterization of cell death pathways in human immunodeficiency virus-associated encephalitis, Am. J. Pathol. 167, 695.
90. Fujita, K., Kato, T., Shibayama, K., Imada, H., Yamauchi, M., Yoshimoto, N., Miyachi, E., and Nagata, Y. (2006) Protective effect against 17beta-estradiol on neuronal apoptosis in hippocampus tissue following transient ischemia/recirculation in mongolian gerbils via down-regulation of tissue transglutaminase activity, Neurochem. Res. 31, 1059.
91. Hwang, I. K., Yoo, K. Y., Yi, S. S., Kim, I. Y., Hwang, H. S., Lee, K. Y., Choi, S. M., Lee, I. S., Yoon, Y. S., Kim, S. Y., Won, M. H., and Seong, J. K. (2009) Expression of tissue-type transglutaminase (tTG) and the effect of tTG inhibitor on the hippocampal CA1 region after transient ischemia in gerbils, Brain Res. 1263, 134.
92. Mastroberardino, P. G., Iannicola, C., Nardacci, R., Bernassola, F., De Laurenzi, V., Melino, G., Moreno, S., Pavone, F., Oliverio, S., Fesus, L., and Piacentini, M. (2002) 'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease, Cell Death Differ. 9, 873.
93. Sarnelli, G., De Giorgio, R., Gentile, F., Cali, G., Grandone, I., Rocco, A., Cosenza, V., Cuomo, R., and D'Argenio, G. (2009) Myenteric neuronal loss in rats with experimental colitis: role of tissue transglutaminase-induced apoptosis, Dig. Liver Dis. 41, 185.
94. Nemes, Z., Petrovski, G., Aerts, M., Sergeant, K., Devreese, B., and Fesus, L. (2009) Transglutaminase-mediated intramolecular cross-linking of membrane-bound alphasynuclein promotes amyloid formation in Lewy bodies, J. Biol. Chem. 284, 27252.
95. Griffin, M. and Verderio, E. (2000) Tissue transglutaminase in cell death, Symp. Soc. Exp. Biol. 52, 223.
96. Kroemer, G., El-Deiry, W. S., Golstein, P., Peter, M. E., Vaux, D., Vandenabeele, P., Zhivotovsky, B., Blagosklonny, M. V., Malorni, W., Knight, R. A., Piacentini, M., Nagata, S., and Melino, G. (2005) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death, Cell Death Differ. 12(Suppl 2), 1463.
97. Krysko, D. V., D'Herde, K., and Vandenabeele, P. (2006) Clearance of apoptotic and necrotic cells and its immunological consequences, Apoptosis 11, 1709.
98. Piacentini, M. (1999) Apoptosis and autoimmunity: two sides to the coin, Cell Death Differ. 6, 1.
99. Kerr, J. F., Wyllie, A. H., and Currie, A. R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br. J. Cancer 26, 239.
100. Kroemer, G. and Reed, J. C. (2000) Mitochondrial control of cell death, Nat. Med. 6, 513.
101. Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., and Nagata, S. (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD, Nature 391, 43.
102. De Duve, C. (1966) The significance of lysosomes in pathology and medicine, Proc. Inst. Med. Chic. 26, 73.
103. De Duve, C. and Wattiaux, R. (1966) Functions of lysosomes, Annu. Rev. Physiol. 28, 435.
104. Maiuri, M. C., Zalckvar, E., Kimchi, A., and Kroemer, G. (2007) Self-eating and selfkilling: crosstalk between autophagy and apoptosis, Nat. Rev. Mol. Cell Biol. 8, 741.
105. Huang, J. and Klionsky, D. J. (2007) Autophagy and human disease, Cell Cycle 6, 1837.
106. Hotchkiss, R. S., Strasser, A., McDunn, J. E., and Swanson, P. E. (2009) Cell death, N. Engl. J. Med. 361, 1570.
107. Vanlangenakker, N., Vanden Berghe, T., Krysko, D. V., Festjens, N., and Vandenabeele, P. (2008) Molecular mechanisms and pathophysiology of necrotic cell death, Curr. Mol. Med. 8, 207.
108. Zong,W. X. and Thompson, C. B. (2006) Necrotic death as a cell fate, Genes Dev. 20, 1.
109. Galluzzi, L., Maiuri, M. C., Vitale, I., Zischka, H., Castedo, M., Zitvogel, L., and Kroemer, G. (2007) Cell death modalities: classification and pathophysiological implications, Cell Death Differ. 14, 1237.
110. Boya, P., Gonzalez-Polo, R. A., Casares, N., Perfettini, J. L., Dessen, P., Larochette, N., Metivier, D., Meley, D., Souquere, S., Yoshimori, T., Pierron, G., Codogno, P., and Kroemer, G. (2005) Inhibition of macroautophagy triggers apoptosis, Mol. Cell Biol. 25, 1025.
111. Gonzalez-Polo, R. A., Boya, P., Pauleau, A. L., Jalil, A., Larochette, N., Souquere, S., Eskelinen, E. L., Pierron, G., Saftig, P., andKroemer,G. (2005) The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death, J. Cell Sci. 118, 3091.
112. Vandenabeele, P.,Vanden Berghe, T., and Festjens, N. (2006) Caspase inhibitors promote alternative cell death pathways, Sci. STKE 2006, pe44.
113. Grabarek, J., Ardelt, B., Kunicki, J., and Darzynkiewicz, Z. (2002) Detection of in situ activation of transglutaminase during apoptosis: correlation with the cell cycle phase by multiparameter flow and laser scanning cytometry, Cytometry 49, 83.
114. Robitaille, K., Daviau, A., Tucholski, J., Johnson, G. V., Rancourt, C., and Blouin, R. (2004) Tissue transglutaminase triggers oligomerization and activation of dual leucine zipper-bearing kinase in calphostin C-treated cells to facilitate apoptosis, Cell Death Differ. 11, 542.
115. Hwang, J. Y., Mangala, L. S., Fok, J. Y., Lin, Y. G., Merritt, W. M., Spannuth, W. A., Nick, A.M., Fiterman, D. J., Vivas-Mejia, P. E., Deavers,M. T., Coleman, R. L., Lopez-Berestein, G., Mehta, K., and Sood, A. K. (2008) Clinical and biological significance of tissue transglutaminase in ovarian carcinoma, Cancer Res. 68, 5849.
116. Shao, M., Cao, L., Shen, C., Satpathy, M., Chelladurai, B., Bigsby, R. M., Nakshatri, H., and Matei, D. (2009) Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase, Cancer Res. 69, 9192.
117. Caraglia, M., Marra, M., Giuberti, G., D'Alessandro, A. M., Beninati, S., Lentini, A., Pepe, S., Boccellino, M., and Abbruzzese, A. (2002) Theophylline-induced apoptosis is paralleled by protein kinase A-dependent tissue transglutaminase activation in cancer cells, J. Biochem. (Tokyo) 132, 45.
118. Jang, J. H., Park, J. S., Lee, T. J., and Kwon, T. K. (2009) Transglutaminase 2 expression levels regulate sensitivity to cystamine plus TRAIL-mediated apoptosis, Cancer Lett. 287, 224.
119. Fok, J. Y. andMehta, K. (2007) Tissue transglutaminase induces the release of apoptosis inducing factor and results in apoptotic death of pancreatic cancer cells, Apoptosis 12, 1455.
120. Cao, L., Petrusca, D. N., Satpathy, M., Nakshatri, H., Petrache, I., and Matei, D. (2008) Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling, Carcinogenesis 29, 1893.
121. Joseph, B., Lefebvre, O., Mereau-Richard, C., Danze, P. M., Belin-Plancot, M. T., and Formstecher, P. (1998) Evidence for the involvement of both retinoic acid receptor-and retinoic X receptor-dependent signaling pathways in the induction of tissue transglutaminase and apoptosis in the human myeloma cell line RPMI 8226, Blood 91, 2423.
122. Lefebvre, O., Wouters, D., Mereau-Richard, C., Facon, T., Zandecki, M., Formstecher, P., and Belin, M. T. (1999) Induction of apoptosis by all-trans retinoic acid in the human myeloma cell line RPMI 8226 and negative regulation of some of its typical morphological features by dexamethasone, Cell Death Differ. 6, 433.
123. Yuan, L., Behdad, A., Siegel, M., Khosla, C., Higashikubo, R., and Rich, K. M. (2008) Tissue transgluaminase 2 expression in meningiomas, J. Neurooncol. 90, 125.
124. Yuan, L., Choi, K., Khosla, C., Zheng, X., Higashikubo, R., Chicoine, M. R., and Rich, K. M. (2005) Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas, Mol. Cancer Ther. 4, 1293.
125. Esposito, C., Marra, M., Giuberti, G., D'Alessandro, A. M., Porta, R., Cozzolino, A., Caraglia, M., and Abbruzzese, A. (2003) Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells, Biochem. J. 370, 205.
126. Verma, A., Guha, S., Diagaradjane, P., Kunnumakkara, A. B., Sanguino, A. M., Lopez-Berestein, G., Sood, A. K., Aggarwal, B. B., Krishnan, S., Gelovani, J. G., and Mehta, K. (2008) Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer, Clin. Cancer Res. 14, 2476.
127. Verma, A., Guha, S.,Wang, H., Fok, J.Y.,Koul, D., Abbruzzese, J., and Mehta, K. (2008) Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells, Clin. Cancer Res. 14, 1997.
128. Melino, G., Annicchiarico-Petruzzelli, M., Piredda, L., Candi, E., Gentile, V., Davies, P. J., and Piacentini, M. (1994) Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells, Mol. Cell Biol. 14, 6584.
129. Piacentini, M., Fesus, L., Farrace, M. G., Ghibelli, L., Piredda, L., andMelino, G. (1991) The expression of " tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis), Eur. J. Cell Biol. 54, 246.
130. Antonyak,M. A., Miller, A.M., Jansen, J.M., Boehm, J. E., Balkman, C. E.,Wakshlag, J. J., Page, R. L., and Cerione, R. A. (2004) Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells, J. Biol. Chem. 279, 41461.
131. Datta, S., Antonyak,M. A., and Cerione, R. A. (2006) Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis, Biochemistry 45, 13163.
132. Kim, D. S., Park, K. S., and Kim, S. Y. (2009) Silencing of TGase 2 sensitizes breast cancer cells to apoptosis by regulation of survival factors, Front. Biosci. 14, 2514.
133. Park, K. S., Han, B. G., Lee, K. H., Kim, D. S., Kim, J. M., Jeon, H., Kim, H. S., Suh, S. W., Lee, E. H., Kim, S. Y., and Lee, B. I. (2009) Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells, Cancer Lett. 274, 201.
134. El-Metwally, T. H., Hussein, M. R., Pour, P. M., Kuszynski, C. A., and Adrian, T. E. (2005) Natural retinoids inhibit proliferation and induce apoptosis in pancreatic cancer cells previously reported to be retinoid resistant, Cancer Biol. Ther. 4, 474.
135. Kweon, S. M., Lee, Z. W., Yi, S. J., Kim, Y. M., Han, J. A., Paik, S. G., and Ha, S. S. (2004) Protective role of tissue transglutaminase in the cell death induced by TNF-alpha in SH-SY5Y neuroblastoma cells, J. Biochem. Mol. Biol. 37, 185.
136. Yu, J. W. and Shi, Y. (2008) FLIP and the death effector domain family, Oncogene 27, 6216.
137. Green, D. R. (2005) Apoptotic pathways: ten minutes to dead, Cell 121, 671.
138. Scorrano, L. (2008) Caspase-8 goes cardiolipin: a new platform to provide mitochondria with microdomains of apoptotic signals? J. Cell Biol. 183, 579.
139. Chipuk, J. E. and Green, D. R. (2008) How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?, Trends Cell Biol. 18, 157.
140. Scorrano, L. and Korsmeyer, S. J. (2003) Mechanisms of cytochrome c release by proapoptotic BCL-2 family members, Biochem. Biophys. Res. Commun. 304, 437.
141. Scorrano, L., Oakes, S. A., Opferman, J. T., Cheng, E. H., Sorcinelli, M. D., Pozzan, T., and Korsmeyer, S. J. (2003) BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis, Science 300, 135.
142. Chipuk, J. E., Fisher, J. C., Dillon, C. P., Kriwacki, R.W., Kuwana, T., and Green, D. R. (2008) Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins, Proc. Natl. Acad. Sci. U.S.A. 105, 20327.
143. Danial, N. N. (2007) BCL-2 family proteins: critical checkpoints of apoptotic cell death, Clin Cancer Res 13, 7254.
144. Lomonosova, E. andChinnadurai, G. (2008) BH3-only proteins in apoptosis and beyond: an overview, Oncogene 27(Suppl 1), S2.
145. Susnow, N., Zeng, L., Margineantu, D., and Hockenbery, D. M. (2009) Bcl-2 family proteins as regulators of oxidative stress, Semin. Cancer Biol. 19, 42.
146. Youle, R. J. and Strasser, A. (2008) The BCL-2 protein family: opposing activities that mediate cell death, Nat. Rev. Mol. Cell Biol. 9, 47.
147. Piacentini, M., Amendola, A., Ciccosanti, F., Falasca, L., Farrace, M. G., Mastroberardino, P. G., Nardacci, R., Oliverio, S., Piredda, L., Rodolfo, C., and Autuori, F. (2005) Type 2 transglutaminase and cell death, Prog. Exp. Tumor Res. 38, 58.
148. Piacentini, M., Autuori, F., Dini, L., Farrace, M. G., Ghibelli, L., Piredda, L., and Fesus, L. (1991) " Tissue" transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor-stimulation, Cell Tissue Res. 263, 227.
149. Piacentini, M., Ceru, M. P., Dini, L., Di Rao,M., Piredda, L., Thomazy, V., Davies, P. J., and Fesus, L. (1992) In vivo and in vitro induction of 'tissue' transglutaminase in rat hepatocytes by retinoic acid, Biochim. Biophys. Acta 1135, 171.
150. Dhar, S. K. and St Clair, D. K. (2009) Nucleophosmin blocks mitochondrial localization of p53 and apoptosis, J. Biol. Chem. 284, 16409.
151. Battaglia, G., Farrace, M. G., Mastroberardino, P. G.,Viti, I., Fimia, G. M.,Van Beeumen, J., Devreese, B., Melino, G., Molinaro, G., Busceti, C. L., Biagioni, F., Nicoletti, F., and Piacentini, M. (2007) Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders, J. Neurochem. 100, 36.
152. Szondy, Z., Mastroberardino, P. G., Varadi, J., Farrace, M. G., Nagy, N., Bak, I., Viti, I., Wieckowski, M. R., Melino, G., Rizzuto, R., Tosaki, A., Fesus, L., and Piacentini, M. (2006) Tissue transglutaminase (TG2) protects cardiomyocytes against ischemia/reperfusion injury by regulating ATP synthesis, Cell Death Differ. 13, 1827.
153. Malorni,W., Farrace, M. G., Rodolfo, C., and Piacentini, M. (2008) Type 2 transglutaminase in neurodegenerative diseases: the mitochondrial connection, Curr. Pharm. Des. 14, 278.
154. Lesort, M., Attanavanich, K., Zhang, J., and Johnson, G. V. (1998) Distinct nuclear localization and activity of tissue transglutaminase, J. Biol. Chem. 273, 11991.
155. Robitaille, H., Proulx, R., Robitaille, K., Blouin, R., and Germain, L. (2005) The mitogen-activated protein kinase kinase kinase dual leucine zipper-bearing kinase (DLK) acts as a key regulator of keratinocyte terminal differentiation, J. Biol. Chem. 280, 12732.
156. Robitaille, K., Daviau, A., Lachance, G., Couture, J. P., and Blouin, R. (2008) Calphostin C-induced apoptosis is mediated by a tissue transglutaminase-dependent mechanism involving the DLK/JNK signaling pathway, Cell Death Differ. 15, 1522.
157. Boosen,M., Vetterkind, S., Kubicek, J., Scheidtmann, K. H., Illenberger, S., and Preuss, U. (2009) Par-4 is an essential downstream target of DAP-like kinase (Dlk) in Dlk/Par-4-mediated apoptosis, Mol. Biol. Cell 20, 4010.
158. Kogel, D., Reimertz, C., Mech, P., Poppe, M., Fruhwald, M. C., Engemann, H., Scheidtmann, K. H., and Prehn, J. H. (2001), Dlk/ZIP kinase-induced apoptosis in human medulloblastoma cells: requirement of the mitochondrial apoptosis pathway, Br. J. Cancer 85, 1801.
159. Verderio, E. A., Telci, D., Okoye, A., Melino, G., and Griffin, M. (2003) A novel RGD-independent cell adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis, J. Biol. Chem. 278, 42604.
160. Collighan, R. J. and Griffin, M. (2009) Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications, Amino Acids 36, 659.
161. Gundemir, S. and Johnson, G. V. (2009) Intracellular localization and conformational state of transglutaminase 2: implications for cell death, PLoS One 4, e6123.
162. Antonyak, M. A., Singh, U. S., Lee, D. A., Boehm, J. E., Combs, C., Zgola, M. M., Page, R. L., and Cerione, R. A. (2001) Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis, J. Biol. Chem. 276, 33582.
163. Beck, K. E., De Girolamo, L. A., Griffin, M., and Billett, E. E. (2006) The role of tissue transglutaminase in 1-methyl-4-phenylpyridinium (MPP+)-induced toxicity in differentiated human SH-SY5Y neuroblastoma cells, Neurosci. Lett. 405, 46.
164. Verma, A. and Mehta, K. (2007) Transglutaminase-mediated activation of nuclear transcription factor-kappaB in cancer cells: a new therapeutic opportunity, Curr. Cancer Drug Targets 7, 559.
165. Verma, A. and Mehta, K. (2007) Tissue transglutaminase-mediated chemoresistance in cancer cells, Drug Resist. Update 10, 144.
166. Boehm, J. E., Singh, U., Combs, C., Antonyak, M. A., and Cerione, R. A. (2002) Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb, J. Biol. Chem. 277, 20127.
167. Antonyak, M. A., Boehm, J. E., and Cerione, R. A. (2002) Phosphoinositide 3-kinase activity is required for retinoic acid-induced expression and activation of the tissue transglutaminase, J. Biol. Chem. 277, 14712.
168. Antonyak, M. A., McNeill, C. J., Wakshlag, J. J., Boehm, J. E., and Cerione, R. A. (2003) Activation of the Ras-ERK pathway inhibits retinoic acid-induced stimulation of tissue transglutaminase expression in NIH3T3 cells, J. Biol. Chem. 278, 15859.
169. Antonyak, M. A., Jansen, J. M., Miller, A. M., Ly, T. K., Endo, M., and Cerione, R. A. (2006) Two isoforms of tissue transglutaminase mediate opposing cellular fates, Proc. Natl. Acad. Sci. U.S.A. 103, 18609.
170. Mizushima, N. and Klionsky, D. J. (2007) Protein turnover via autophagy: implications for metabolism, Annu. Rev. Nutr. 27, 19.
171. Mizushima, N. (2007) Autophagy: process and function, Genes Dev. 21, 2861.
172. Kundu, M. and Thompson, C. B. (2008) Autophagy: basic principles and relevance to disease, Annu. Rev. Pathol. 3, 427.
173. Levine, B. and Klionsky, D. J. (2004) Development by self-digestion: molecular mechanisms and biological functions of autophagy, Dev. Cell 6, 463.
174. Levine, B. and Kroemer, G. (2008) Autophagy in the pathogenesis of disease, Cell 132, 27.
175. Amano, A., Nakagawa, I., and Yoshimori, T. (2006) Autophagy in innate immunity against intracellular bacteria, J. Biochem. 140, 161.
176. Levine, B. and Deretic, V. (2007) Unveiling the roles of autophagy in innate and adaptive immunity, Nat. Rev. Immunol. 7, 767.
177. Gorski, S.M., Chittaranjan, S., Pleasance, E. D., Freeman, J. D., Anderson, C. L.,Varhol, R. J., Coughlin, S.M., Zuyderduyn, S. D., Jones, S. J., and Marra,M. A. (2003) A SAGE approach to discovery of genes involved in autophagic cell death, Curr. Biol. 13, 358.
178. Hou, Y. C., Hannigan, A. M., and Gorski, S.M. (2009) An executioner caspase regulates autophagy, Autophagy 5, 530.
179. Klionsky, D. J. (2007) Autophagy: from phenomenology to molecular understanding in less than a decade, Nat. Rev. Mol. Cell Biol. 8, 931.
180. Shintani, T. and Klionsky,D. J. (2004) Cargo proteins facilitate the formation of transport vesicles in the cytoplasm to vacuole targeting pathway, J. Biol. Chem. 279, 29889.
181. Baehrecke, E. H. (2005) Autophagy: dual roles in life and death? Nat. Rev. Mol. Cell Biol. 6, 505.
182. Lum, J. J., DeBerardinis, R. J., and Thompson, C. B. (2005) Autophagy in metazoans: cell survival in the land of plenty, Nat. Rev. Mol. Cell Biol. 6, 439.
183. Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T., and Thompson, C. B. (2005) Growth factor regulation of autophagy and cell survival in the absence of apoptosis, Cell 120, 237.
184. Levine, B. and Abrams, J. (2008) p53: The Janus of autophagy? Nat. Cell Biol. 10, 637.
185. Meijer, A. J. and Codogno, P. (2006) Signalling and autophagy regulation in health, aging and disease, Mol. Aspects Med. 27, 411.
186. Meley, D., Bauvy, C., Houben-Weerts, J. H., Dubbelhuis, P. F., Helmond, M. T., Codogno, P., and Meijer, A. J. (2006) AMP-activated protein kinase and the regulation of autophagic proteolysis, J. Biol. Chem. 281, 34870.
187. Rubinsztein, D. C., Gestwicki, J. E.,Murphy, L. O., and Klionsky, D. J. (2007) Potential therapeutic applications of autophagy, Nat. Rev. Drug Discov. 6, 304.
188. Mizushima, N. and Yoshimori, T. (2007) How to interpret LC3 immunoblotting, Autophagy 3, 542.
189. Qiao, L. and Zhang, J. (2009) Inhibition of lysosomal functions reduces proteasomal activity, Neurosci. Lett. 456, 15.
190. Turmaine, M., Raza, A., Mahal, A., Mangiarini, L., Bates, G. P., and Davies, S. W. (2000) Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease, Proc. Natl. Acad. Sci. U.S.A. 97, 8093.
191. Vonsattel, J. P. and DiFiglia, M. (1998) Huntington disease, J. Neuropathol. Exp. Neurol. 57, 369.
192. D'Eletto,M., Farrace, M. G., Falasca, L., Reali, V., Oliverio, S., Melino, G., Griffin,M., Fimia, G. M., and Piacentini, M. (2009) Transglutaminase 2 is involved in autophagosome maturation, Autophagy 5, 1145.
193. Kim, I., Rodriguez-Enriquez, S., and Lemasters, J. J. (2007) Selective degradation of mitochondria by mitophagy, Arch. Biochem. Biophys. 462, 245.
194. Skill, N. J., Johnson, T. S., Coutts, I. G., Saint, R. E., Fisher, M., Huang, L., El Nahas, A. M., Collighan, R. J., and Griffin, M. (2004) Inhibition of transglutaminase activity reduces extracellular matrix accumulation induced by high glucose levels in proximal tubular epithelial cells, J. Biol. Chem. 279, 47754.
195. Juprelle-Soret, M., Wattiaux-De Coninck, S., and Wattiaux, R. (1984) Presence of a transglutaminase activity in rat liver lysosomes, Eur. J. Cell Biol. 34, 271.
196. Akar, U., Ozpolat, B., Mehta, K., Fok, J., Kondo, Y., and Lopez-Berestein, G. (2007) Tissue transglutaminase inhibits autophagy in pancreatic cancer cells, Mol. Cancer Res. 5, 241.
197. Monastyrska, I., Rieter, E., Klionsky, D. J., and Reggiori, F. (2009) Multiple roles of the cytoskeleton in autophagy, Biol. Rev. Camb. Philos. Soc. 84, 431.
198. Csosz, E., Mesko, B., and Fesus, L. (2009) Transdab wiki: the interactive transglutaminase substrate database on web 2.0 surface, Amino Acids 36, 615.
199. De Laurenzi, V. and Melino, G. (2001) Gene disruption of tissue transglutaminase, Mol. Cell Biol. 21, 148.
200. Nanda, N., Iismaa, S. E., Owens, W. A., Husain, A., Mackay, F., and Graham, R. M. (2001) Targeted inactivation of Gh/tissue transglutaminase II, J. Biol. Chem. 276, 20673.
201. Szondy, Z., Sarang, Z., Molnar, P., Nemeth, T., Piacentini, M., Mastroberardino, P. G., Falasca, L., Aeschlimann, D., Kovacs, J., Kiss, I., Szegezdi, E., Lakos, G., Rajnavolgyi, E., Birckbichler, P. J., Melino, G., and Fesus, L. (2003) Transglutaminase 2-/-mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells, Proc. Natl. Acad. Sci. U.S.A. 100, 7812.
202. Bernassola, F., Federici, M., Corazzari, M., Terrinoni, A., Hribal, M. L., De Laurenzi, V., Ranalli, M.,Massa, O., Sesti, G., McLean,W. H., Citro, G., Barbetti, F., and Melino, G. (2002) Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient, Faseb J. 16, 1371.
203. Molberg, O., McAdam, S. N., and Sollid, L. M. (2000) Role of tissue transglutaminase in celiac disease, J. Pediatr. Gastroenterol. Nutr. 30, 232.
204. Hoffner, G. and Djian, P. (2005) Transglutaminase and diseases of the central nervous system, Front. Biosci. 10, 3078.
205. Issa, R., Zhou, X., Constandinou, C. M., Fallowfield, J., Millward-Sadler, H., Gaca, M. D., Sands, E., Suliman, I., Trim, N., Knorr, A., Arthur, M. J., Benyon, R. C., and Iredale, J. P. (2004) Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking, Gastroenterology 126, 1795.
206. Mirza, A., Liu, S. L., Frizell, E., Zhu, J., Maddukuri, S., Martinez, J., Davies, P., Schwarting, R., Norton, P., and Zern, M. A. (1997) A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB, Am. J. Physiol. 272, G281.
207. Johnson, T. S., El-Koraie, A. F., Skill, N. J., Baddour, N. M., El Nahas, A. M., Njloma, M., Adam, A. G., and Griffin, M. (2003) Tissue transglutaminase and the progression of human renal scarring, J. Am. Soc. Nephrol. 14, 2052.
208. Mangala, L. S., Fok, J. Y., Zorrilla-Calancha, I. R., Verma, A., and Mehta, K. (2007) Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells, Oncogene 26, 2459.
209. Facchiano, F., Facchiano, A., and Facchiano, A. M. (2006) The role of transglutaminase-2 and its substrates in human diseases, Front. Biosci. 11, 1758.
210. Eguchi, K. (2001) Apoptosis in autoimmune diseases, Intern. Med. 40, 275.
211. Navratil, J. S., Sabatine, J. M., and Ahearn, J. M. (2004) Apoptosis and immune responses to self, Rheum. Dis. Clin. North Am. 30, 193.
212. Savill, J., Dransfield, I., Gregory, C., and Haslett, C. (2002) A blast from the past: clearance of apoptotic cells regulates immune responses, Nat. Rev. Immunol. 2, 965.
213. Falasca, L., Iadevaia, V., Ciccosanti, F., Melino, G., Serafino, A., and Piacentini, M. (2005) Transglutaminase type II is a key element in the regulation of the antiinflammatory response elicited by apoptotic cell engulfment, J. Immunol. 174, 7330.
214. Neininger, A., Kontoyiannis, D., Kotlyarov, A., Winzen, R., Eckert, R., Volk, H. D., Holtmann, H., Kollias, G., and Gaestel, M. (2002) MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels, J. Biol. Chem. 277, 3065.
215. Suzuki, K., Hino, M., Kutsuna, H., Hato, F., Sakamoto, C., Takahashi, T., Tatsumi, N., and Kitagawa, S. (2001) Selective activation of p38 mitogen-activated protein kinase cascade in human neutrophils stimulated by IL-1beta, J. Immunol. 167, 5940.
216. Lee, J. C. and Young, P. R. (1996) Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms, J. Leukoc. Biol. 59, 152.
217. Alleva, D. G., Johnson, E. B., Wilson, J., Beller, D. I., and Conlon, P. J. (2001) SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL-12(p40) gene, suggesting a conserved pathway for the induction of organ-specific autoimmunity, J. Leukoc. Biol. 69, 440.
218. Alleva, D. G., Pavlovich, R. P., Grant, C., Kaser, S. B., and Beller, D. I. (2000) Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factoralpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice, Diabetes 49, 1106.
219. Liu, J. and Beller, D. (2002) Aberrant production of IL-12 by macrophages from several autoimmune-prone mouse strains is characterized by intrinsic and unique patterns of NF-kappa B expression and binding to the IL-12 p40 promoter, J. Immunol. 169, 581.
220. Qu, X., Zou, Z., Sun, Q., Luby-Phelps, K., Cheng, P., Hogan, R. N., Gilpin, C., and Levine, B. (2007) Autophagy gene-dependent clearance of apoptotic cells during embryonic development, Cell 128, 931.
221. Lolis, E. and Bucala, R. (2003) Therapeutic approaches to innate immunity: severe sepsis and septic shock, Nat. Rev. Drug Discov. 2, 635.
222. Perl,M., Chung, C. S., Garber,M., Huang, X., and Ayala, A. (2006) Contribution of antiinflammatory/ immune suppressive processes to the pathology of sepsis, Front. Biosci. 11, 272.
223. Bantel, H. and Schulze-Osthoff, K. (2009) Cell death in sepsis: a matter of how, when, and where, Crit. Care 13, 173.
224. Perl,M., Chung, C. S., Swan, R., and Ayala, A. (2007) Role of Programmed Cell Death in the Immunopathogenesis of Sepsis, Drug Discov. Today Dis. Mech. 4, 223.
225. Bowness, J. M. and Tarr, A. H. (1997) Increase in transglutaminase and its extracellular products in response to an inflammatory stimulus by lipopolysaccharide, Mol. Cell Biochem. 169, 157.
226. Leu, R. W., Herriott, M. J., Moore, P. E., Orr, G. R., and Birckbichler, P. J. (1982) Enhanced transglutaminase activity associated with macrophage activation. Possible role in Fc-mediated phagocytosis, Exp. Cell Res. 141, 191.
227. Park, K. C., Chung, K. C., Kim, Y. S., Lee, J., Joh, T. H., and Kim, S. Y. (2004) Transglutaminase 2 induces nitric oxide synthesis in BV-2 microglia, Biochem. Biophys. Res. Commun. 323, 1055.
228. Falasca, L., Farrace, M. G., Rinaldi, A., Tuosto, L., Melino, G., and Piacentini, M. (2008) Transglutaminase type II is involved in the pathogenesis of endotoxic shock, J. Immunol. 180, 2616.
229. Liu, S. F. and Malik, A. B. (2006) NF-kappa B activation as a pathological mechanism of septic shock and inflammation, Am. J. Physiol. Lung Cell Mol. Physiol. 290, L622.
230. Baeuerle, P. A. and Baltimore, D. (1988) I kappa B: a specific inhibitor of the NF-kappa B transcription factor, Science 242, 540.
231. Lee, J., Kim, Y. S., Choi, D. H., Bang, M. S., Han, T. R., Joh, T. H., and Kim, S. Y. (2004) Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia, J. Biol. Chem. 279, 53725.
232. Hasosah, M., Davidson, G., and Jacobson, K. (2009) Persistent elevated tissuetransglutaminase in cystic fibrosis, J. Paediatr. Child Health 45, 172.
233. Maiuri, L., Luciani, A., Giardino, I., Raia, V., Villella, V. R., D'Apolito, M., Pettoello-Mantovani, M., Guido, S., Ciacci, C., Cimmino, M., Cexus, O. N., Londei, M., and Quaratino, S. (2008) Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation, J. Immunol. 180, 7697.
234. Luciani, A., Villella, V. R., Vasaturo, A., Giardino, I., Raia, V., Pettoello-Mantovani,M., D'Apolito,M., Guido, S., Leal, T., Quaratino, S., andMaiuri, L. (2009) SUMOylation of tissue transglutaminase as link between oxidative stress and inflammation, J. Immunol. 183, 2775.
235. Johnson, W. G. (2000) Late-onset neurodegenerative diseases-the role of protein insolubility, J. Anat. 196(Pt 4), 609.
236. Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M.,Masters, C. L.,Grzeschik,K. H., Multhaup, G., Beyreuther, K., and Muller-Hill, B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor, Nature 325, 733.
237. Masters, C. L.,Multhaup, G., Simms, G., Pottgiesser, J.,Martins, R. N., and Beyreuther, K. (1985) Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels, Embo J. 4, 2757.
238. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., and Beyreuther, K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome, Proc. Natl. Acad. Sci. U.S.A. 82, 4245.
239. Delacourte, A. andDefossez, A. (1986) Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments, J. Neurol. Sci. 76, 173.
240. Kosik, K. S., Joachim, C. L., and Selkoe, D. J. (1986) Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A. 83, 4044.
241. Biernat, J., et al. (1992) The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region, Embo J. 11, 1593.
242. Crowther, R. A., Olesen, O. F., Jakes, R., and Goedert, M. (1992) The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's disease, FEBS Lett. 309, 199.
243. Goedert, M., Spillantini, M. G., Cairns, N. J., and Crowther, R. A. (1992) Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms, Neuron 8, 159.
244. Appelt, D. M., Kopen, G. C., Boyne, L. J., and Balin, B. J. (1996) Localization of transglutaminase in hippocampal neurons: implications for Alzheimer's disease, J. Histochem. Cytochem. 44, 1421.
245. Miller,C.C. and Anderton, B. H. (1986) Transglutaminase and the neuronal cytoskeleton in Alzheimer's disease, J. Neurochem. 46, 1912.
246. Appelt, D. M. and Balin, B. J. (1997) The association of tissue transglutaminase with human recombinant tau results in the formation of insoluble filamentous structures, Brain Res. 745, 21.
247. Miller, M. L. and Johnson, G. V. (1995) Transglutaminase cross-linking of the tau protein, J. Neurochem. 65, 1760.
248. Gusella, J. F. and MacDonald, M. E. (1993) Hunting for Huntington's disease, Mol. Genet. Med. 3, 139.
249. Andrew, S. E., et al. (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease, Nat. Genet. 4, 398.
250. Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E.,Wanker, E. E.,Mangiarini, L., and Bates, G. P. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation, Cell 90, 537.
251. DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., and Aronin, N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain, Science 277, 1990.
252. Saudou, F., Finkbeiner, S., Devys, D., and Greenberg, M. E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions, Cell 95, 55.
253. Gentile, V., Sepe, C., Calvani, M.,Melone,M. A., Cotrufo, R., Cooper, A. J., Blass, J. P., and Peluso, G. (1998) Tissue transglutaminase-catalyzed formation of high-molecularweight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases, Arch. Biochem. Biophys. 352, 314.
254. Lesort, M., Tucholski, J., Miller, M. L., and Johnson, G. V. (2000) Tissue transglutaminase: a possible role in neurodegenerative diseases, Prog. Neurobiol. 61, 439.
255. Lesort, M., Tucholski, J., Zhang, J., and Johnson, G. V. (2000) Impaired mitochondrial function results in increased tissue transglutaminase activity in situ, J. Neurochem. 75, 1951.
256. Winslow, A. R. and Rubinsztein, D. C. (2008) Autophagy in neurodegeneration and development, Biochim. Biophys. Acta 1782, 723.
257. Williams, A., Jahreiss, L., Sarkar, S., Saiki, S., Menzies, F. M., Ravikumar, B., and Rubinsztein, D. C. (2006) Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications, Curr. Top. Dev. Biol. 76, 89.
258. Yue, Z., Horton, A., Bravin,M., DeJager, P. L., Selimi, F., and Heintz, N. (2002) A novel protein complex linking the delta 2 glutamate receptor and autophagy: implications for neurodegeneration in lurcher mice, Neuron 35, 921.
259. Martinez-Vicente, M. and Cuervo, A. M. (2007) Autophagy and neurodegeneration: when the cleaning crew goes on strike, Lancet Neurol 6, 352.
260. Strnad, P., Harada, M., Siegel, M., Terkeltaub, R. A., Graham, R. M., Khosla, C., and Omary, M. B. (2007) Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement, Gastroenterology 132, 1515.
261. Fujitani, Y., Kawamori, R., and Watada, H. (2009) The role of autophagy in pancreatic beta-cell and diabetes, Autophagy 5, 280.
262. Jung, H. S., Chung, K. W., Won Kim, J., Kim, J., Komatsu, M., Tanaka, K., Nguyen, Y. H., Kang, T. M., Yoon, K. H., Kim, J. W., Jeong, Y. T., Han, M. S., Lee, M. K., Kim, K.W., Shin, J., and Lee, M. S. (2008) Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia, Cell Metab. 8, 318.
263. Gottlieb, R. A. and Mentzer, R. M. (2010) Autophagy during cardiac stress: joys and frustrations of autophagy, Annu. Rev. Physiol. 72, 45.
264. Gustafsson, A. B. and Gottlieb, R. A. (2009) Autophagy in ischemic heart disease, Circ. Res. 104, 150.
265. Rothermel, B. A. and Hill, J. A. (2008) Autophagy in load-induced heart disease, Circ. Res. 103, 1363.
266. Wang, Z. V., Rothermel, B. A., and Hill, J. A. (2010), Autophagy in hypertensive heart disease, J. Biol. Chem. 285, 8509.
267. Terman, A. and Brunk, U. T. (2005) The aging myocardium: roles of mitochondrial damage and lysosomal degradation, Heart Lung Circ. 14, 107.
268. Terman, A. and Brunk, U. T. (2005) Autophagy in cardiac myocyte homeostasis, aging, and pathology, Cardiovasc. Res. 68, 355.
269. Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., Asahi, M., Nishida, K., Hori, M., Mizushima, N., and Otsu, K. (2007) The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress, Nat. Med. 13, 619.
270. Tannous, P., Zhu, H., Nemchenko, A., Berry, J. M., Johnstone, J. L., Shelton, J. M., Miller, F. J., Jr., Rothermel, B. A., and Hill, J. A. (2008) Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy, Circulation 117, 3070.
271. Porrello, E. R., D'Amore, A., Curl, C. L., Allen, A. M., Harrap, S. B., Thomas, W. G., and Delbridge, L. M. (2009) Angiotensin II type 2 receptor antagonizes angiotensin II type 1 receptor-mediated cardiomyocyte autophagy, Hypertension 53, 1032.
272. Porrello, E. R. and Delbridge, L. M. (2009) Cardiomyocyte autophagy is regulated by angiotensin II type 1 and type 2 receptors, Autophagy 5, 1215.
273. AbdAlla, S., Lother, H., Langer, A., El Faramawy, Y., and Quitterer, U. (2004) Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis, Cell 119, 343.
274. Sane, D. C., Kontos, J. L., and Greenberg, C. S. (2007) Roles of transglutaminases in cardiac and vascular diseases, Front. Biosci. 12, 2530.